VUMC in the news, Jan. 4, 2022Dec. 29, 2021, 10:04 AM
A roundup of a few recent stories from the press about Vanderbilt University Medical Center:
William Schaffner, MD, professor of Preventive Medicine, continues to be one of the most in-demand sources about COVID-19, influenza and other subjects in the news. The emergence of the omicron variant has especially given him opportunities to speak to reporters and provide information and context. Among the news organizations he has spoken with recently: The Washington Post, The Wall Street Journal, NBC News, CNN, Healthline, Medical News Today, The Hill, Reuters, HealthDay via U.S. News and World Report, and CNBC.
A New York Times story, headlined, “They Lost Three Daughters to Sickle Cell. Can They Save a Fourth?” quotes Michael DeBaun, MD, MPH, J.C. Peterson, M.D. Professor of Pediatrics.
Paras Karmacharya, MBBS, instructor in Medicine, is quoted in a STAT News story headlined, “How medicine erased Black women from a ‘white man’s disease.’”
The New York Times quoted Jennifer Andrews, MD, medical director of VUMC’s Blood Bank, for a story about the national shortage of blood and the need for donations.
Keipp Talbot, MD, associate professor of Medicine in the Division of Infectious Diseases, was quoted in stories in The Washington Post and Forbes about the preference for Moderna and Pfizer COVID-19 vaccines over the Johnson & Johnson vaccine due to the latter’s link to blood clots in a small number of those receiving it.
Buddy Creech, MD, director, of the Vanderbilt Vaccine Research Program, was interviewed by ABC News for a story about the large numbers of children who are still unvaccinated against COVID-19.
Healio and Reuters were among the news organizations that interviewed Wayne Ray, PhD, professor of Health Policy, for stories about his JAMA study showing strong evidence that the medication apixaban (Eliquis) is preferable to rivaroxaban (Xarelto) for stoke prevention in patients with atrial fibrillation, with both reduced rates of severe bleeding complications as well as strokes.
Stephen Camarata, PhD, professor of hearing and speech services, is quoted in a U.S. News and World Report story about the importance of teletherapy for children developing their speech skills.